Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014 (2014), Article ID 149878, 5 pages
http://dx.doi.org/10.1155/2014/149878
Case Report

Chromothripsis: Basis of a Concurrent Unusual Association between Myelodysplastic Syndrome and Primary Ciliary Dyskinesia

Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ 07740, USA

Received 18 July 2014; Revised 12 August 2014; Accepted 21 August 2014; Published 1 September 2014

Academic Editor: Marie-Christine Kyrtsonis

Copyright © 2014 Abhinav Agrawal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. E. Rollison, N. Howlader, M. T. Smith et al., “Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001–2004, using data from the NAACCR and SEER programs,” Blood, vol. 112, no. 1, pp. 45–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Goldberg, E. Chen, M. Corral et al., “Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries,” Journal of Clinical Oncology, vol. 28, no. 17, pp. 2847–2852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. W. Corkey, H. Levison, and J. A. P. Turner, “The immotile cilia syndrome. A longitudinal survey,” The American Review of Respiratory Disease, vol. 124, no. 5, pp. 544–548, 1981. View at Google Scholar · View at Scopus
  4. H. Kollberg, B. Mossberg, B. A. Afzelius, K. Philipson, and P. Camner, “Cystic fibrosis compared with the immotile-cilia syndrome. A study of mucociliary clearance, ciliary ultrastructure, clinical picture and ventilatory function,” Scandinavian Journal of Respiratory Diseases, vol. 59, no. 6, pp. 297–306, 1978. View at Google Scholar · View at Scopus
  5. M. A. Zariwala, M. R. Knowles, and M. W. Leigh, “Primary ciliary dyskinesia,” in GeneReviews, R. A. Pagon, M. P. Adam, H. H. Ardinger et al., Eds., University of Washington, Seattle, Wash, USA, 2007, http://www.ncbi.nlm.nih.gov/books/NBK1122. View at Google Scholar
  6. C. E. Kuehni, T. Frischer, M.-P. F. Strippoli et al., “Factors influencing age at diagnosis of primary ciliary dyskinesia in European children,” European Respiratory Journal, vol. 36, no. 6, pp. 1248–1258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. JS. Lucas, WT. Walker, CE. Kuehni et al., “Primary ciliary dyskinesia,” in Orphan Lung Diseases, J.-F. Courdier, Ed., pp. 201–217, European Respiratory Monograph, 2011. View at Google Scholar
  8. X. Ma, “Epidemiology of myelodysplastic syndromes,” The American Journal of Medicine, vol. 125, no. 7, pp. S2–S5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Sonoda, K. Kawaguchi, K. Ohba, H. Madokoro, and S. Ohdo, “Partial monosomy 5p and partial trisomy 5q due to paternal pericentric inversion 5(p15.1q35.1),” Japanese Journal of Human Genetics, vol. 34, no. 2, pp. 129–134, 1989. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Bocian, K. Suchenek, E. Obersztyn, B. Nowakowska, and T. Mazurczak, “Recombination aneusomy of subtelomeric regions of chromosome 5, resulting from a large familial pericentric inversion inv(5)(p15.33q35.3),” Journal of Applied Genetics, vol. 46, no. 1, pp. 109–114, 2005. View at Google Scholar · View at Scopus
  11. A. Basinko, M. L. Giovannucci Uzielli, G. Scarselli, M. Priolo, G. Timpani, and M. de Braekeleer, “Clinical and molecular cytogenetic studies in ring chromosome 5: report of a child with congenital abnormalities,” European Journal of Medical Genetics, vol. 55, no. 2, pp. 112–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. A. Beemer, H. F. De France, and I. J. M. Rosina-Angelista, “Familial partial monosomy 5p and trisomy 5q; three cases due to paternal pericentric inversion 5 (p151q333),” Clinical Genetics, vol. 26, no. 3, pp. 209–215, 1984. View at Google Scholar · View at Scopus
  13. Z. Zemanova, K. Michalova, H. Buryova et al., “Involvement of deleted chromosome 5 in complex chromosomal aberrations in newly diagnosed myelodysplastic syndromes (MDS) is correlated with extremely adverse prognosis,” Leukemia Research, vol. 38, no. 5, pp. 537–544, 2014. View at Publisher · View at Google Scholar
  14. F. Magrangeas, H. Avet-Loiseau, N. C. Munshi, and S. Minvielle, “Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients,” Blood, vol. 118, no. 3, pp. 675–678, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Zhang, M. Leibowitz, and D. Pellman, “Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements,” Genes & Development, vol. 27, no. 23, pp. 2513–2530, 2013. View at Google Scholar
  16. Ciliary Dyskinesia, Primary, 7, CILD7, http://omim.org/entry/611884.
  17. G. Garcia-Manero, “Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management,” The American Journal of Hematology, vol. 87, no. 7, pp. 692–701, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Greenberg, C. Cox, M. M. LeBeau et al., “International scoring system for evaluating prognosis in myelodysplastic syndromes,” Blood, vol. 89, no. 6, pp. 2079–2088, 1997. View at Google Scholar · View at Scopus
  19. P. L. Greenberg, H. Tuechler, J. Schanz et al., “Revised international prognostic scoring system for myelodysplastic syndromes,” Blood, vol. 120, no. 12, pp. 2454–2465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Garcia-Manero and P. Fenaux, “Hypomethylating agents and other novel strategies in myelodysplastic syndromes,” Journal of Clinical Oncology, vol. 29, no. 5, pp. 516–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Jädersten, L. Malcovati, I. Dybedal et al., “Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome,” Journal of Clinical Oncology, vol. 26, no. 21, pp. 3607–3613, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Kantarjlan, J.-P. J. Issa, C. S. Rosenfeld et al., “Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study,” Cancer, vol. 106, no. 8, pp. 1794–1803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. List, G. Dewald, J. Bennett et al., “Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion,” The New England Journal of Medicine, vol. 355, no. 14, pp. 1456–1465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Wattel, S. de Botton, J. L. Laï et al., “Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders,” British Journal of Haematology, vol. 98, no. 4, pp. 983–991, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Chang, B. E. Storer, B. L. Scott et al., “Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: Similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders,” Blood, vol. 110, no. 4, pp. 1379–1387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Santamaria, S. Montella, H. A. W. M. Tiddens et al., “Structural and functional lung disease in primary ciliary dyskinesia,” Chest, vol. 134, no. 2, pp. 351–357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. K. Marthin, N. Petersen, L. T. Skovgaard, and K. G. Nielsen, “Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study,” The American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 11, pp. 1262–1268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. G. Noone, M. W. Leigh, A. Sannuti et al., “Primary ciliary dyskinesia: diagnostic and phenotypic features,” The American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 4, pp. 459–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. M. R. Knowles, L. A. Daniels, S. D. Davis, M. A. Zariwala, and M. W. Leigh, “Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease,” American Journal of Respiratory and Critical Care Medicine, vol. 188, no. 8, pp. 913–922, 2013. View at Publisher · View at Google Scholar
  30. A. Bush, P. Cole, M. Hariri et al., “Primary ciliary dyskinesia: diagnosis and standards of care,” European Respiratory Journal, vol. 12, no. 4, pp. 982–988, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Tkebuchava, U. Niederhäuser, W. Weder et al., “Kartagener's syndrome: clinical presentation and cardiosurgical aspects,” Annals of Thoracic Surgery, vol. 62, no. 5, pp. 1474–1479, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Bartoloni, J.-L. Blouin, Y. Pan et al., “Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10282–10286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. G. C. Schwabe, K. Hoffmann, N. T. Loges et al., “Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations,” Human Mutation, vol. 29, no. 2, pp. 289–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Knowles, M. W. Leigh, J. L. Carson et al., “Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure,” Thorax, vol. 67, no. 5, pp. 433–441, 2012. View at Publisher · View at Google Scholar · View at Scopus